Home/Filings/4/0000950170-23-052934
4//SEC Filing

CUMMING JOHN W 4

Accession 0000950170-23-052934

CIK 0001492674other

Filed

Oct 10, 8:00 PM ET

Accepted

Oct 11, 5:00 PM ET

Size

6.6 KB

Accession

0000950170-23-052934

Insider Transaction Report

Form 4
Period: 2023-09-15
Transactions
  • Exercise/Conversion

    Common Stock

    2023-09-15+2,6005,256 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-152,6000 total
    Common Stock (2,600 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]On October 11, 2022, the reporting person was granted 2,600 restricted stock units that vested on the earlier of (i) October 11, 2023, and (ii) the date of the next annual meeting of stockholders.

Documents

1 file

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001181189

Filing Metadata

Form type
4
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 5:00 PM ET
Size
6.6 KB